HTC Says Its Crypto-Friendly Smartphone Will Support Litecoin

Litecoin creator Charlie Lee revealed Monday he will serve as an advisor to HTC’s Exodus, the blockchain-powered smartphone.

Fierce Biotech

FDA greenlights ICU AI for predicting fatal COVID-19 complications

FDA greenlights ICU AI for predicting fatal COVID-19 complications chale Thu, 05/28/2020 - 10:37

Conor Hale

Bristol Myers jumps into synthetic lethality with $65M Repare deal

Bristol Myers jumps into synthetic lethality with $65M Repare deal aalidrus Thu, 05/28/2020 - 10:10

Amirah Al Idrus

After passing safety hurdle, Orpheris kick-starts COVID-19 cytokine storm efficacy test

After passing safety hurdle, Orpheris kick-starts COVID-19 cytokine storm efficacy test badams Thu, 05/28/2020 - 10:05

Ben Adams

PureTech eyes clinical trial in long-term COVID-19 complications

PureTech eyes clinical trial in long-term COVID-19 complications ntaylor Thu, 05/28/2020 - 08:15

Nick Paul

Protalix, Chiesi edge close to potential Fabry disease approval

Protalix, Chiesi edge close to potential Fabry disease approval badams Thu, 05/28/2020 - 07:50

Ben Adams

Biospace.com

BioCryst Prices Public Offering of Common Stock and Pre-Funded Warrants

BioCryst Pharmaceuticals, Inc. announced the pricing of an underwritten public offering of 18,711,113 shares of its common stock, offered at a price to the public of $4.50 per share.

Boston Scientific Completes Approximately $2.0 Billion Aggregate Offerings of Common Stock and Mandatory Convertible Preferred Stock

Boston Scientific Corporation completed the concurrent offerings of 29,382,500 shares of its common stock, which includes the exercise in full by the underwriters of their option to purchase up to 3,832,500 additional shares of common stock

Genprex Announces Receipt of $2.5 Million in Cash from Recent Warrant Exercises

Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX ), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, announced today that warrants to purchase approximately 5.4 million shares of common stock issued in connection with capital raises in May 2018 and November 2019 with two institutional investors have been […]

Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $50.00 per share. All of the shares are being sold by Arena. The gross proceeds from the offering are expected to be $275.0 million , before deducting […]

HemaFlo Therapeutics, Inc. Engages VENTURE.co Brokerage Services for $7.5 MM Private Placement Offering

Venture.co Brokerage Services, LLC ("VENTURE.co") today announces a private capital investment opportunity into HemaFlo Therapeutics, Inc. ("HemaFlo"). VENTURE.co, the Managing Broker-Dealer, will facilitate the $7.5 million ca

Feedity.com/biospace

Gynesonics Receives FDA Clearance to Market Next Generation Sonata® System 2.1

Gynesonics, a women’s healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its next generation Sonata® System 2.1 for Transcervical Fibroid Ablation (TFA). The Sonata techno

Ashvattha Therapeutics Subsidiary Orpheris Announces FDA Agreement to Initiate Phase 2 Study Evaluating OP-101 in Severe COVID-19 Patients

Orpheris , a subsidiary of Ashvattha Therapeutics , a biotech company focused on developing novel dendrimer-based therapies to treat unmet medical needs in inflammatory, oncology, and ocular diseases today announced the U.S. Food and Drug

Biopharma Update on the Novel Coronavirus: May 28

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 28, 2020.

Centinel Spine Announces FDA Approval for the Manufacturing Transfer of prodisc® Technology

Centinel Spine®, LLC, the largest privately-held spine company focused on anterior column reconstruction, today announced FDA approval for the manufacturing transfer of both the prodisc® C Cervical Total Disc Replacement and prodisc® L Lumbar Total Disc Replacement systems to new strategic vendors.

Rebif® U.S. Label Now Includes Pregnancy Outcomes and Lactation Information to Help Inform Treatment Decisions for Women with MS

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, announced today the U.S. Food and Drug Administration (FDA) has approved the inclusion of new safety data on pregnancy and breastfeeding in the prescribing information for Rebif® (interferon beta-1a),

Technology

Investigation finds many tenant screening services, relying on algorithms to find infractions and widely used by landlords, often produce flawed reports (The Markup)

The Markup: Investigation finds many tenant screening services, relying on algorithms to find infractions and widely used by landlords, often produce flawed reports — Computer algorithms that scan everything from terror watch lists to eviction records spit out flawed tenant screening reports.

Salesforce Q1: revenue of $4.87B, up 30% YoY, subscription and support revenue $4.58B, up 31% YoY, Q2 guidance lower than expected; stock down ~4% after hours (Jordan Novet/CNBC)

Jordan Novet / CNBC: Salesforce Q1: revenue of $4.87B, up 30% YoY, subscription and support revenue $4.58B, up 31% YoY, Q2 guidance lower than expected; stock down ~4% after hours — - Salesforce's guidance for the full fiscal year was softer than what analysts had expected. — The company announced the departure of co-CEO Keith […]

VMware reports Q1 revenue of $2.73B, up 12% YoY, subscription and SaaS revenue up 39% YoY; stock up ~9% after hours (Larry Dignan/ZDNet)

Larry Dignan / ZDNet: VMware reports Q1 revenue of $2.73B, up 12% YoY, subscription and SaaS revenue up 39% YoY; stock up ~9% after hours — VMware handily topped earnings estimates for its first quarter. — VMware delivered better-than-expected first quarter results as its subscription and software as a service revenue jumped 39% from a […]

Trump signs an EO designed to limit Section 230 protections that shield social media companies from liability for the content that users post on their platforms (Rashaan Ayesh/Axios)

Rashaan Ayesh / Axios: Trump signs an EO designed to limit Section 230 protections that shield social media companies from liability for the content that users post on their platforms — President Trump signed an executive order on Thursday designed to limit the legal protections that shield social media companies …

Google says it will resume its SameSite cookie update starting July 14, alongside the launch of Chrome 84; the update was rolled back in April due to COVID-19 (Aliya Chaudhry/The Verge)

Aliya Chaudhry / The Verge: Google says it will resume its SameSite cookie update starting July 14, alongside the launch of Chrome 84; the update was rolled back in April due to COVID-19 — The updates were rolled back in April in light of COVID-19 — Google announced on Thursday that it will bring its […]